Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
Identifieur interne : 000714 ( 2020/Analysis ); précédent : 000713; suivant : 000715Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
Auteurs : Azar Hadadi [Iran] ; Masoud Mortezazadeh [Iran] ; Kasra Kolahdouzan [Iran] ; Golbarg Alavian [Iran]Source :
- Journal of medical virology [ 1096-9071 ] ; 2020.
Abstract
An 80-year-old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever and critically low O2 saturation and definitive chest CT scan findings in favor of COVID-19 and positive PCR results in 48 h. He received antiviral treatment plus recombinant human Erythropoietin(rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus. This article is protected by copyright. All rights reserved.
DOI: 10.1002/jmv.25839
PubMed: 32270515
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000267
- to stream PubMed, to step Curation: 000267
- to stream PubMed, to step Checkpoint: 000558
- to stream Ncbi, to step Merge: 003842
- to stream Ncbi, to step Curation: 003842
- to stream Ncbi, to step Checkpoint: 003842
- to stream Main, to step Merge: 000714
- to stream Main, to step Curation: 000714
- to stream Main, to step Exploration: 000714
- to stream 2020, to step Extraction: 000714
Links to Exploration step
pubmed:32270515Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</title><author><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name><affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name><affiliation wicri:level="1"><nlm:affiliation>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32270515</idno><idno type="pmid">32270515</idno><idno type="doi">10.1002/jmv.25839</idno><idno type="wicri:Area/PubMed/Corpus">000267</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000267</idno><idno type="wicri:Area/PubMed/Curation">000267</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000267</idno><idno type="wicri:Area/PubMed/Checkpoint">000558</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000558</idno><idno type="wicri:Area/Ncbi/Merge">003842</idno><idno type="wicri:Area/Ncbi/Curation">003842</idno><idno type="wicri:Area/Ncbi/Checkpoint">003842</idno><idno type="wicri:Area/Main/Merge">000714</idno><idno type="wicri:Area/Main/Curation">000714</idno><idno type="wicri:Area/Main/Exploration">000714</idno><idno type="wicri:Area/2020/Extraction">000714</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</title><author><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name><affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name><affiliation wicri:level="1"><nlm:affiliation>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name><affiliation wicri:level="1"><nlm:affiliation>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of medical virology</title><idno type="eISSN">1096-9071</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">An 80-year-old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever and critically low O2 saturation and definitive chest CT scan findings in favor of COVID-19 and positive PCR results in 48 h. He received antiviral treatment plus recombinant human Erythropoietin(rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus. This article is protected by copyright. All rights reserved.</div></front></TEI><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name></noRegion><name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name><name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name><name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000714 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000714 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32270515
|texte= Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32270515" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |